List of Hypertrust X‑Chain Customers
Bavaria, 80636,
Germany
Since 2010, our global team of researchers has been studying Hypertrust X‑Chain customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Hypertrust X‑Chain for Blockchain Platform from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Hypertrust X‑Chain for Blockchain Platform include: Roche, a Switzerland based Life Sciences organisation with 112774 employees and revenues of $80.28 billion, Transgene, a France based Life Sciences organisation with 143 employees and revenues of $19.0 million and many others.
Contact us if you need a completed and verified list of companies using Hypertrust X‑Chain, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Hypertrust X‑Chain customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Roche | Life Sciences | 112774 | $80.3B | Switzerland | Hypertrust | Hypertrust X‑Chain | Blockchain Platform | 2020 | n/a |
In 2020, Roche ran a proof-of-concept using Hypertrust X‑Chain to simulate a commercialized personalized cancer therapy supply chain. The engagement used Hypertrust X‑Chain as a Blockchain Platform to validate blockchain-based workflow orchestration and immutable storage for Chain of Identity/Custody, and it was explicitly a PoC rather than a full commercial rollout. The PoC focused on personalized healthcare supply chain processes and regulatory-compliant auditability in the region. Scope emphasized end-to-end traceability for individualized therapy shipments and demonstrable audit trails for compliance review.
Implementation work concentrated on configuring workflow orchestration capabilities and immutable ledger storage common to Blockchain Platform deployments, aligning transaction sequencing and evidence capture to support Chain of Identity/Custody. Functional modules exercised during the PoC included identity and custody ledger entries, transaction orchestration for therapy handling, and audit trail generation for regulatory inspection. Operational coverage targeted supply chain and personalized healthcare functions within the region, with governance and process design oriented toward producing regulatory-compliant auditability. Outcomes documented by the engagement were validation of Hypertrust X‑Chain workflow orchestration and immutable storage for Chain of Identity/Custody as applied to personalized cancer therapy supply chain scenarios.
|
 |
Transgene | Life Sciences | 143 | $19M | France | Hypertrust | Hypertrust X‑Chain | Blockchain Platform | 2020 | n/a |
In 2020, Transgene implemented Hypertrust X‑Chain to orchestrate and provide an immutable audit trail for its personalized therapeutic vaccine TG4050 clinical-trial supply chain in Europe. Hypertrust X‑Chain is a Blockchain Platform used to monitor vein to vein processes and custody and identity flows across stakeholders in clinical trials.
The deployment of Hypertrust X‑Chain for Clinical Trials instrumented ledger-based event recording and chain of custody tracking, capturing custody attestations and sample provenance as immutable entries. Functional capabilities implemented include orchestration of supply chain events, identity assertions for stakeholder participants, and automated audit trail generation to support clinical supply chain and logistics operations as well as clinical site and manufacturing coordination.
Operational scope focused on TG4050 trial activities across Europe, spanning manufacturing, logistics, and clinical site interactions, with governance adjusted to require shared custody attestations and periodic ledger reconciliation workflows. The implementation provided an immutable audit trail and improved trust and traceability during trials as described in the deployment notes.
|
Buyer Intent: Companies Evaluating Hypertrust X‑Chain
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||